Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncotelic Therapeutics Inc OTLC

Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer with a focus on rare pediatric cancers, and addressing the current global pandemic. OT-101 is its lead immuno-oncology drug candidate. OT-101 also has activity against SARS-CoV-2. Its other products under pipeline are Artemisinin, CA4P, and Oxi4503. Currently, the company generates revenues from rendering services to other third-party customers for the development of certain drug products or in connection with certain out-licensing agreements.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Oncotelic Announces Pipeline Presentation and IPO Update of

Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention: https://finance.yahoo.com/news/oncotelic-announces-pipeline-presentation...read more

RE:ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1

finally a US company posting on a day of trading , not like 5 pages of CDN posts for tomorrow,   rate and reply

ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1

ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 (globenewswire.com)  rate and reply

Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as CMO

Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer: https://oncotelic.irpass.com/Oncotelic-Appoints-Fatih-Uckun--M-D---Ph-D---as-Chief-Medical-Officer-5-3-2022  ...read more

Oncotelic Appoints Seymour Fein M.D. as CRO

Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer: https://oncotelic.irpass.com/Oncotelic-Appoints-Seymour-Fein-M-D--as-Chief-Regulatory-Officer-5-4-2022      rate and reply

Oncotelic; Announcing Successful Joint Venture and Diving in

Oncotelic; Announcing Successful Joint Venture and Diving into Benefits for Shareholders: https://www.youtube.com/watch?v=sr3qbea_mCM      rate and reply

Oncotelic presentation at MedInvest Pharmaceutical & Biotech

Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology Investor Conference: https://www.youtube.com/watch?v=Ys4V5qZt4sA      rate and reply

Oncotelic JV Financing

Oncotelic JV Financing: https://www.youtube.com/watch?v=k0Zj59shmw0  rate and reply

Oncotelic; Looking at Industry Comparison for the Company

Oncotelic; Looking at Industry Comparison for the Company: https://www.youtube.com/watch?v=Dnkmg0k7W0U      rate and reply

Oncotelic; Discussing the Company's Development Pipeline

Oncotelic; Discussing the Company's Development Pipeline: https://www.youtube.com/watch?v=FPBbAif6M9I      rate and reply

Oncotelic; Diving into the Company's Outlook for 2022

Oncotelic; Diving into the Company's Outlook for 2022: https://www.youtube.com/watch?v=FPBbAif6M9I      rate and reply

Oncotelic to Present New Studies on its TGF-ß Program at the

Oncotelic to Present New Studies on its TGF- Program at the American Association for Cancer Research (AACR) Annual Meeting 2022: https://apnews.com/press-release/globe-newswire/covid-science...read more

Oncotelic; An Introduction to CFO Amit Shah & His Industry B

https://www.youtube.com/watch?v=D4k5OEUYvbk  rate and reply

Oncotelic Initiates Phase 1 Trial Evaluating CA4P...

Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma (yahoo.com)  rate and reply

Oncotelic Announces that ORF8 Mutations are Driving the...

Oncotelic Announces that ORF8 Mutations are Driving the Evolution of the Delta and the Omicron Variants: https://www.globenewswire.com/news-release/2021/12/22/2356662/0/en/ONCOTELIC-ANNOUNCES...read more

Oncotelic’s Dr. Anthony Maida to Present at 2nd Annual TGF-β

Oncotelic’s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022 | News Direct  rate and reply

Mesothelioma Clinical Trial to Involve Drug Studied forCOVID

Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19: https://www.asbestos.com/news/2021/12/07/mesothelioma-trial-covid-19-drug/  rate and reply

Oncotelic 2021 Q3 Report, Litchfield reiterates $4 12 month

Oncotelic 2021 Q3 Report, Litchfield reiterates $4 12 month PT: https://www.otcmarkets.com/financialReportViewer?id=314866  rate and reply

Biotech Growth Stocks Set to Benefit from Rising Volatility

https://www.benzinga.com/pressreleases/21/12/ab24422302/biotech-growth-stocks-set-to-benefit-from-rising-volatility-regn-otlc-amgn-ilmn-lly-gild-mrk  rate and reply

New Oncotelic Therapeutics Inc (OTLC) Stock Analysis

https://www.youtube.com/watch?v=x7b7ZXxAeiA  rate and reply